Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04447573 · UNKNOWN
Trial details
- NCT number
- NCT04447573
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2022-08-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.